Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer
- Authors:
View Affiliations
Affiliations: Department of Anatomy and Cell Biology, College of Medicine, Hanyang University, Seoul 133-791, Republic of Korea
- Published online on: July 30, 2012 https://doi.org/10.3892/ol.2012.834
-
Pages:
1033-1036
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Kruppel-like factor 4 (KLF4) is a key transcriptional regulator of cell differentiation and proliferation and an altered expression of KLF4 has been reported in a number of human malignancies. In the present study, we investigated KLF4 expression and its role in cell proliferation in advanced epithelial ovarian cancer (EOC). We compared KLF4, Bcl-2 and Bax transcript levels in ovaries isolated from advanced EOC and normal control ovaries. In addition, the KLF4 gene was transduced into ovarian cancer cells and transcript levels of Bcl-2 and Bax and cell proliferation were analyzed by real‑time RT-PCR and MTT assays, respectively. Ovarian KLF4 expression and Bcl-2/Bax ratios were downregulated in most cases of advanced EOC. In addition, KLF4 overexpression in ovarian cancer cells increased the Bcl-2/Bax ratio. However, MTT analysis indicated that the overexpression of KLF4 had no effect on the proliferation of ovarian cancer cells. The inactivation of KLF4 is frequently observed in ovarian cancers and a reduced expression of KLF4 in the ovarian cancers may lead to a reduction in the Bcl-2/Bax ratio. The latter has a role in predicting cancer grade, although its exact role in ovarian carcinogenesis requires clarification.
View References
|
1.
|
A JemalT MurrayE WardA SamuelsRC TiwariA
GhafoorEJ FeuerMJ ThunCancer statistics, 2005CA Cancer J
Clin551030200510.3322/canjclin.55.1.10
|
|
2.
|
LA Garrett-SinhaH EberspaecherMF SeldinB
de CrombruggheA gene for a novel zinc-finger protein expressed in
differentiated epithelial cells and transiently in certain
mesenchymal cellsJ Biol
Chem2713138431390199610.1074/jbc.271.49.31384
|
|
3.
|
JM ShieldsRJ ChristyVW YangIdentification
and characterization of a gene encoding a gut-enriched Kruppel-like
factor expressed during growth arrestJ Biol
Chem2712000920017199610.1074/jbc.271.33.200098702718
|
|
4.
|
KW FosterAR FrostP McKie-BellCY LinJA
EnglerWE GrizzleJM RuppertIncrease of GKLF messenger RNA and
protein expression during progression of breast cancerCancer
Res6064886495200011103818
|
|
5.
|
AY PandyaLI TalleyAR FrostTJ FitzgeraldV
TrivediM ChakravarthyDC ChhiengWE GrizzleJA EnglerH
KrontirasNuclear localization of KLF4 is associated with an
aggressive phenotype in early-stage breast cancerClin Cancer
Res1027092719200410.1158/1078-0432.CCR-03-048415102675
|
|
6.
|
AM GhalebJP KatzKH KaestnerJX DuVW
YangKruppel-like factor 4 exhibits antiapoptotic activity following
gamma-radiation-induced DNA
damageOncogene2623652373200710.1038/sj.onc.121002217016435
|
|
7.
|
S OhnishiS OhnamiF LaubK AokiK SuzukiY
KanaiK HagaM AsakaF RamirezT YoshidaDownregulation and growth
inhibitory effect of epithelial-type Kruppel-like transcription
factor KLF4, but not KLF5, in bladder cancerBiochem Biophys Res
Commun308251256200310.1016/S0006-291X(03)01356-112901861
|
|
8.
|
J WangRF PlaceV HuangX WangEJ NoonanCE
MagyarJ HuangLC LiPrognostic value and function of KLF4 in prostate
cancer: RNAa and vector-mediated overexpression identify KLF4 as an
inhibitor of tumor cell growth and migrationCancer
Res701018210191201010.1158/0008-5472.CAN-10-241421159640
|
|
9.
|
ZN OltvaiCL MillimanSJ KorsmeyerBcl-2
heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell
deathCell74609619199310.1016/0092-8674(93)90509-O8358790
|
|
10.
|
FJ de la TorreA GarciaA Gil-MorenoJ
PlanagumaJ ReventosS Ramon y CajalJ XercavinsApoptosis in
epithelial ovarian tumours Prognostic significance of clinical and
histopathologic factors and its association with the
immunohistochemical expression of apoptotic regulatory proteins
(p53, bcl-2 and bax)Eur J Obstet Gynecol Reprod
Biol1301211282007
|
|
11.
|
M SchuyerME van der BurgSC
Henzen-LogmansJH FieretJG KlijnMP LookJA FoekensG StoterEM
BernsReduced expression of BAX is associated with poor prognosis in
patients with epithelial ovarian cancer: a multifactorial analysis
of TP53, p21, BAX and BCL-2Br J
Cancer8513591367200110.1054/bjoc.2001.210111720475
|
|
12.
|
Z LiJ ZhaoQ LiW YangQ SongW LiJ LiuKLF4
promotes hydrogen-peroxide-induced apoptosis of chronic myeloid
leukemia cells involving the bcl-2/bax pathwayCell Stress
Chaperones15905912201010.1007/s12192-010-0199-520401760
|
|
13.
|
BD RowlandDS PeeperKLF4, p21 and
context-dependent opposing forces in cancerNat Rev
Cancer61123200610.1038/nrc178016372018
|
|
14.
|
M GodmannC KosanR BehrKruppel-like factor
4 is widely expressed in the mouse male and female reproductive
tract and responds as an immediate early gene to activation of the
protein kinase A in TM4 Sertoli
cellsReproduction139771782201010.1530/REP-09-053120051481
|
|
15.
|
AA JazaeriCS AwtreyGV ChandramouliYE
ChuangJ KhanC SotiriouO AprelikovaCJ YeeKK ZornMJ BirrerJC BarrettJ
BoydGene expression profiles associated with response to
chemotherapy in epithelial ovarian cancersClin Cancer
Res1163006310200510.1158/1078-0432.CCR-04-268216144934
|
